1800 Participants Needed

M2VA Pain Care Pathway for Pain

(M2VAPCP Trial)

CL
Overseen ByChristina Lazar, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this 2-cohort, cluster randomized, type 2 hybrid trial is to test the effectiveness, cost-effectiveness and patient-level effects of an implementation facilitation strategy in helping M2VA case managers adopt a Military2VA Pain Care Pathway (M2VAPCP) intervention. The main questions it aims to answer are: Will adding implementation facilitation to training-as-usual for M2VAPCP result in a higher proportion of Veterans who receive M2VAPCP compared to training-as-usual alone? Will adding implementation facilitation to training-as-usual for M2VAPCP result in better adherence to the M2VAPCP protocol compared to training-as-usual alone? Will implementation facilitation improve Veterans' clinical outcomes (pain, risky substance use) and increase the number of non-pharmacological pain treatments used compared to training-as-usual alone?

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the M2VA Pain Care Pathway treatment?

Research shows that clinical pathways, like the M2VA Pain Care Pathway, can improve patient care by integrating evidence-based practices and enhancing teamwork among healthcare providers. These pathways have been effective in other settings, such as hospitals and community teams, by standardizing care and improving outcomes.12345

Is the M2VA Pain Care Pathway generally safe for humans?

The M2VA Pain Care Pathway, which involves strategies like Implementation Facilitation, has been used in various studies to support safe opioid prescribing and pain management. These studies have not reported any significant safety concerns, suggesting it is generally safe for humans.678910

How is the M2VA Pain Care Pathway treatment different from other pain management treatments?

The M2VA Pain Care Pathway is unique because it uses an implementation facilitation strategy, which involves interactive problem-solving and support to help healthcare providers implement a collaborative care program for pain management. This approach focuses on reducing high-dose opioid use and promoting safer, multi-modal pain care models, which is different from traditional pain management methods that may not emphasize provider support and collaborative care.911121314

Research Team

MR

Marc Rosen, MD

Principal Investigator

Yale University

Eligibility Criteria

This trial is for veterans dealing with pain and at risk of or currently facing substance use issues, specifically opioid abuse. It's designed to help case managers better adopt a special care pathway to improve these veterans' quality of life.

Inclusion Criteria

Study enrollment is within one year of ending military service
Lives within the catchment area of a participating site
I have filed a claim for a service-connected musculoskeletal disorder.

Exclusion Criteria

Does not have a landline or cell phone to complete study assessments
Still on active duty
I am unable to understand and give consent for treatment.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

M2VA case managers receive an initial 8-hour virtual didactic and experiential workshop on Motivational Interviewing and M2VAPCP protocol

1 day
1 virtual workshop

Implementation Facilitation

Implementation facilitation strategy to support the use of M2VAPCP, including external facilitation team and multifaceted activities

21 months

Follow-up

Participants are monitored for safety and effectiveness after treatment, focusing on pain and substance use outcomes

36 weeks

Treatment Details

Interventions

  • Implementation Facilitation
  • M2VA Pain Care Pathway (M2VAPCP)
Trial OverviewThe study tests if adding extra support (implementation facilitation) helps case managers more effectively use the M2VA Pain Care Pathway compared to just standard training. The goal is to see if this leads to better care and outcomes for veterans.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Implementation Facilitation + Training-As-UsualExperimental Treatment2 Interventions
M2VA case managers at sites randomized to IF+TAU will receive the M2VAPCP training workshop described above and IF delivered virtually for 21 months after receiving the M2VAPCP training workshop. IF for this trial will be organized around three major components: 1) an external facilitation team consisting of clinical and implementation experts who will work with internal facilitators at each site; 2) multifaceted activities to support the use of M2VAPCP; and 3) ongoing formative evaluation.
Group II: Training-As-UsualActive Control1 Intervention
M2VA case managers at sites randomized to TAU will receive an initial 8-hour virtual didactic and experiential workshop conducted by an experienced Motivational Interviewing and M2VAPCP trainer, Dr. Martino, who is a longstanding member of the Motivational Interviewing Network of Trainers. The first four hours of the workshop will focus on principles and practices of Motivational Interviewing. The last four hours will be a review the M2VAPCP protocol, with demonstration and practice of its elements. Following the workshop, case managers will have up to seven opportunities to practice M2VAPCP with simulated patients over a 21-month period

Implementation Facilitation is already approved in United States for the following indications:

🇺🇸
Approved in United States as Implementation Facilitation for:
  • Improving pain care pathways
  • Enhancing non-pharmacological pain treatments
  • Reducing risky substance use

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

VA Connecticut Healthcare System

Collaborator

Trials
86
Recruited
8,800+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+

Findings from Research

Implementing clinical pathways can improve the efficiency and cost-effectiveness of patient care, but translating these pathways from concept to practice is challenging due to various organizational and personal barriers.
Successful pathway development requires clear goals, stakeholder engagement, and strong institutional support, as demonstrated by experiences in implementing specific care pathways for cystectomy and pressure ulcers.
The development and implementation of an integrated multidisciplinary clinical pathway.Ramos, MC., Ratliff, C.[2019]
A comprehensive care pathway for managing COPD exacerbations was developed, consisting of 38 evidence-based interventions and 39 indicators (24 process and 15 outcome), validated by nine multidisciplinary teams in Belgium.
The eight-step method used to create this care pathway can serve as a model for other healthcare teams to standardize clinical content for various patient populations, ensuring effective and evidence-based care.
Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation.Lodewijckx, C., Decramer, M., Sermeus, W., et al.[2021]
A clinical pathways program was successfully developed and disseminated across a large academic healthcare system, resulting in 202 pathways created between February 2016 and April 2018, primarily in oncology, pulmonary/critical care, and cardiovascular medicine.
The program utilized a cloud-based technology platform to enhance accessibility and engagement, with 1279 registered users and an average of 2150 monthly views of the pathways, demonstrating effective integration of evidence-based practices into patient care.
Using a 10-step framework to support the implementation of an evidence-based clinical pathways programme.Flores, EJ., Mull, NK., Lavenberg, JG., et al.[2020]

References

The development and implementation of an integrated multidisciplinary clinical pathway. [2019]
Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation. [2021]
Using a 10-step framework to support the implementation of an evidence-based clinical pathways programme. [2020]
The European quality of care pathways (EQCP) study on the impact of care pathways on interprofessional teamwork in an acute hospital setting: study protocol: for a cluster randomised controlled trial and evaluation of implementation processes. [2021]
The effectiveness of quality improvement tools: joint working in integrated community teams. [2019]
Impact of Clinical Pharmacist Practitioner-Driven High Opioid Dose Reevaluation in Veterans with Chronic Non-Cancer Pain. [2023]
Partner engagement for planning and development of non-pharmacological care pathways in the AIM-Back trial. [2023]
A research agenda for enhancing appropriate opioid prescribing in primary care. [2021]
Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol. [2021]
Impact of COVID-19 pandemic on nonpharmacological pain management trials in military and veteran healthcare settings: an evaluation informed by implementation science. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Improving cancer pain management through a system wide commitment. [2005]
Current interventions to promote safe and appropriate pain management. [2020]
Rationale, design, and implementation protocol of the Dutch clinical practice guideline pain in patients with cancer: a cluster randomised controlled trial with Short Message Service (SMS) and Interactive Voice Response (IVR). [2021]
14.United Statespubmed.ncbi.nlm.nih.gov
Feasibility of Implementation Mapping for Integrative Medical Group Visits. [2022]